Healthcare -
Biotechnology - NASDAQ - US
$ 1.85
4.52 %
$ 3.8 M
Market Cap
0.08
P/E
Price Target
Average
548.65%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
26.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Avenue Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ATXI of $12 , with forecasts ranging from
a
low of
$12 to a high of $12 .
ATXI Lowest Price Target
Wall Street Target
12 USD
548.65%
ATXI Average Price Target
Wall Street Target
12 USD
548.65%
ATXI Highest Price Target
Wall Street Target
12 USD
548.65%
REVENUE FORECAST
Revenue Forecast Chart ATXI
EBIT FORECAST
EBIT Forecast Chart ATXI
NET INCOME FORECAST
Net Income Chart ATXI